Screening Women Aged 50–59 for CRC Using Fecal Occult Blood Test Produces Outcomes Similar to Men Undergoing Screening Colonoscopy

Harrison M. Mooers, Jennifer L. Holub, David Lieberman

Research output: Contribution to journalArticle

Abstract

Background: Average-risk women aged 50–59 years have a lower incidence and mortality of colorectal cancer relative to age-matched men, calling into question the benefit of screening colonoscopy in this age group. Aims: We aimed to determine whether FOBT is an effective initial screening test in 50–59-year-old women. Methods: We conducted a cross-sectional study using a computerized endoscopic report generator. We identified 320,906 individuals who had average-risk screening colonoscopy and 32,369 who had colonoscopy for positive FOBT. The primary outcome was the positive predictive value (PPV) of FOBT for large polyp(s) greater than 9 mm, as a surrogate for advanced neoplasia. Results: Among patients aged 50–59 years undergoing screening colonoscopy, men were more likely than women to have large polyps (6.3 vs 4.2%, p < 0.0001). Black women undergoing screening colonoscopy had higher rates of large polyps compared to non-Black women. The PPV in FOBT-positive men aged 50–54 (11.5%) and 55–59 (14.4%) was higher than in women aged 50–54 (6.1%) and 55–59 (5.4%). Despite this lower PPV, women aged 50–54 with a positive FOBT had a similar rate of large polyps as 50–54-year-old men undergoing screening colonoscopy (6.1 vs 6.3%, p = 0.626). Conclusions: CRC screening with FOBT identifies 50–59-year-old men and women with a higher risk of large polyps. Since younger women have a lower risk of large polyps than men, screening with FOBT in 50–59-year-old non-Black women could be an effective screening strategy, with outcomes similar to the use of screening colonoscopy in 50–59-year-old men.

Original languageEnglish (US)
Pages (from-to)1-6
Number of pages6
JournalDigestive Diseases and Sciences
DOIs
StateAccepted/In press - Jun 13 2018

Fingerprint

Occult Blood
Hematologic Tests
Colonoscopy
Polyps
Colorectal Neoplasms
Age Groups
Cross-Sectional Studies

Keywords

  • Colon cancer
  • FOBT
  • Polyps
  • Screening
  • Women

ASJC Scopus subject areas

  • Physiology
  • Gastroenterology

Cite this

@article{0a2c90efb1fa45b5b3e2b93bd107b402,
title = "Screening Women Aged 50–59 for CRC Using Fecal Occult Blood Test Produces Outcomes Similar to Men Undergoing Screening Colonoscopy",
abstract = "Background: Average-risk women aged 50–59 years have a lower incidence and mortality of colorectal cancer relative to age-matched men, calling into question the benefit of screening colonoscopy in this age group. Aims: We aimed to determine whether FOBT is an effective initial screening test in 50–59-year-old women. Methods: We conducted a cross-sectional study using a computerized endoscopic report generator. We identified 320,906 individuals who had average-risk screening colonoscopy and 32,369 who had colonoscopy for positive FOBT. The primary outcome was the positive predictive value (PPV) of FOBT for large polyp(s) greater than 9 mm, as a surrogate for advanced neoplasia. Results: Among patients aged 50–59 years undergoing screening colonoscopy, men were more likely than women to have large polyps (6.3 vs 4.2{\%}, p < 0.0001). Black women undergoing screening colonoscopy had higher rates of large polyps compared to non-Black women. The PPV in FOBT-positive men aged 50–54 (11.5{\%}) and 55–59 (14.4{\%}) was higher than in women aged 50–54 (6.1{\%}) and 55–59 (5.4{\%}). Despite this lower PPV, women aged 50–54 with a positive FOBT had a similar rate of large polyps as 50–54-year-old men undergoing screening colonoscopy (6.1 vs 6.3{\%}, p = 0.626). Conclusions: CRC screening with FOBT identifies 50–59-year-old men and women with a higher risk of large polyps. Since younger women have a lower risk of large polyps than men, screening with FOBT in 50–59-year-old non-Black women could be an effective screening strategy, with outcomes similar to the use of screening colonoscopy in 50–59-year-old men.",
keywords = "Colon cancer, FOBT, Polyps, Screening, Women",
author = "Mooers, {Harrison M.} and Holub, {Jennifer L.} and David Lieberman",
year = "2018",
month = "6",
day = "13",
doi = "10.1007/s10620-018-5156-7",
language = "English (US)",
pages = "1--6",
journal = "American Journal of Digestive Diseases and Nutrition",
issn = "0163-2116",
publisher = "Plenum Publishers",

}

TY - JOUR

T1 - Screening Women Aged 50–59 for CRC Using Fecal Occult Blood Test Produces Outcomes Similar to Men Undergoing Screening Colonoscopy

AU - Mooers, Harrison M.

AU - Holub, Jennifer L.

AU - Lieberman, David

PY - 2018/6/13

Y1 - 2018/6/13

N2 - Background: Average-risk women aged 50–59 years have a lower incidence and mortality of colorectal cancer relative to age-matched men, calling into question the benefit of screening colonoscopy in this age group. Aims: We aimed to determine whether FOBT is an effective initial screening test in 50–59-year-old women. Methods: We conducted a cross-sectional study using a computerized endoscopic report generator. We identified 320,906 individuals who had average-risk screening colonoscopy and 32,369 who had colonoscopy for positive FOBT. The primary outcome was the positive predictive value (PPV) of FOBT for large polyp(s) greater than 9 mm, as a surrogate for advanced neoplasia. Results: Among patients aged 50–59 years undergoing screening colonoscopy, men were more likely than women to have large polyps (6.3 vs 4.2%, p < 0.0001). Black women undergoing screening colonoscopy had higher rates of large polyps compared to non-Black women. The PPV in FOBT-positive men aged 50–54 (11.5%) and 55–59 (14.4%) was higher than in women aged 50–54 (6.1%) and 55–59 (5.4%). Despite this lower PPV, women aged 50–54 with a positive FOBT had a similar rate of large polyps as 50–54-year-old men undergoing screening colonoscopy (6.1 vs 6.3%, p = 0.626). Conclusions: CRC screening with FOBT identifies 50–59-year-old men and women with a higher risk of large polyps. Since younger women have a lower risk of large polyps than men, screening with FOBT in 50–59-year-old non-Black women could be an effective screening strategy, with outcomes similar to the use of screening colonoscopy in 50–59-year-old men.

AB - Background: Average-risk women aged 50–59 years have a lower incidence and mortality of colorectal cancer relative to age-matched men, calling into question the benefit of screening colonoscopy in this age group. Aims: We aimed to determine whether FOBT is an effective initial screening test in 50–59-year-old women. Methods: We conducted a cross-sectional study using a computerized endoscopic report generator. We identified 320,906 individuals who had average-risk screening colonoscopy and 32,369 who had colonoscopy for positive FOBT. The primary outcome was the positive predictive value (PPV) of FOBT for large polyp(s) greater than 9 mm, as a surrogate for advanced neoplasia. Results: Among patients aged 50–59 years undergoing screening colonoscopy, men were more likely than women to have large polyps (6.3 vs 4.2%, p < 0.0001). Black women undergoing screening colonoscopy had higher rates of large polyps compared to non-Black women. The PPV in FOBT-positive men aged 50–54 (11.5%) and 55–59 (14.4%) was higher than in women aged 50–54 (6.1%) and 55–59 (5.4%). Despite this lower PPV, women aged 50–54 with a positive FOBT had a similar rate of large polyps as 50–54-year-old men undergoing screening colonoscopy (6.1 vs 6.3%, p = 0.626). Conclusions: CRC screening with FOBT identifies 50–59-year-old men and women with a higher risk of large polyps. Since younger women have a lower risk of large polyps than men, screening with FOBT in 50–59-year-old non-Black women could be an effective screening strategy, with outcomes similar to the use of screening colonoscopy in 50–59-year-old men.

KW - Colon cancer

KW - FOBT

KW - Polyps

KW - Screening

KW - Women

UR - http://www.scopus.com/inward/record.url?scp=85048457996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048457996&partnerID=8YFLogxK

U2 - 10.1007/s10620-018-5156-7

DO - 10.1007/s10620-018-5156-7

M3 - Article

SP - 1

EP - 6

JO - American Journal of Digestive Diseases and Nutrition

JF - American Journal of Digestive Diseases and Nutrition

SN - 0163-2116

ER -